Our Team

Martin Zentgraf has almost 40 years of leadership in the pharma and medtech industry, including 6 years as a chairman of the Federal Association of the Pharmaceutical Industry (BPI) and over 10 years as a board member (BPI).

Martin began his career at Byk Gulden (now Takeda) as a Business Development and Product Manager and was responsible for various successful licensing projects and launches. Thereafter he was responsible for a number of successful launches and sales campaigns at Glaxo(GSK) as Group Head of Marketing. He then joined BOC Ohmeda as Head of the worldwide operating BU Woundcare and Surgical Implants.

Some years after that and for more than 20 years, Martin became and was the Managing Director and Speaker of the Board of management of Desitin Arzneimittel GmbH, a European specialty pharmaceutical company focused on the CNS and rare diseases markets.  While at Desitin he was responsible generally for the whole company with a focus on strategic direction, M&A and other business development initiatives and for the commercial organization. Under his leadership, the company grew multiples in sales, Ebit and even more in value.

Most recently, he worked as an independent consultant with expertise in pharmaceuticals, digital therapies and medical devices. His professional experience includes a variety of leadership positions within the healthcare industry.

Martin received a MD from the University of Münster and earned his Doctor title shortly after. Martin is fluent in German, Spanish, and English.